NEWS
Recent Updates (2025)
Upcoming
Phase III trial initiation for Kinisoquin™ in cancer-associated thrombosis (CAT)
Phase III trial initiation for Kinisoquin™ in cancer-associated thrombosis (CAT)
Phase III in Sickle Cell Disease (SCD)
Phase III in Sickle Cell Disease (SCD)
Phase II trial with Administration for Strategic Preparedness and Response (ASPR)
Phase II trial with Administration for Strategic Preparedness and Response (ASPR)
Kinisoquin™ is an investigational therapy in Phase 3 clinical development. It has not been approved for use by any regulatory authority.
© 2025 Quercis Pharma. All rights reserved.
Designed by 12y.design
© 2025 Quercis Pharma. All rights reserved.
Designed by 12y.design
© 2025 Quercis Pharma. All rights reserved.
Designed by 12y.design